Novelion Therapeutics Inc (NVLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVLN | PIRS | IMRN | ||
| Company | Novelion Therapeutics Inc | Pieris Pharmaceuticals Inc | Immuron Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.60 | 11.33 | 2.32 | ||
| High | 0.68 | 11.36 | 2.33 | ||
| Low | 0.54 | 11.13 | 2.25 | ||
| Last | 0.68 | 11.36 | 2.25 | ||
| Change | -0.02 | +0.14 | -0.09 | ||
| % Change | -3.34% | +1.25% | -3.75% | ||
| Volume | 238,300 | 6,526 | 11,659 | ||
| 20-Day Average Volume | 206,970 | 25,389 | 7,343 | ||
| Previous Close | 0.70 | 11.22 | 2.34 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.79 | 11.49 | 2.45 | ||
| 20-Day Raw Stochastic | 19.18% | 27.62% | 7.26% | ||
| 20-Day Relative Strength | 44.72% | 39.10% | 44.35% | ||
| Weighted Alpha | -44.97 | -44.08 | -43.33 | ||
| Today's Opinion | 64% Sell | 100% Sell | 32% Buy | ||
| Previous Opinion | 64% Sell | 100% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Sell | 72% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.87% since 10/01/19 | +1.97% since 05/08/24 | -10.05% since 05/08/24 | ||
| Low | 0.54 on 10/08/19 | 10.87 on 05/14/24 | 2.25 on 05/15/24 | ||
| High | 0.74 on 10/04/19 | 11.36 on 05/15/24 | 2.48 on 05/09/24 | ||
| 1-Month | |||||
| %Chg | +3.03% since 09/06/19 | -16.47% since 04/15/24 | -13.08% since 04/15/24 | ||
| Low | 0.54 on 10/08/19 | 10.60 on 05/03/24 | 2.15 on 04/16/24 | ||
| High | 1.27 on 09/18/19 | 13.84 on 04/16/24 | 2.65 on 04/26/24 | ||
| 3-Month | |||||
| %Chg | -11.68% since 07/08/19 | -10.52% since 02/15/24 | +24.39% since 02/15/24 | ||
| Low | 0.54 on 10/08/19 | 10.60 on 05/03/24 | 1.65 on 03/04/24 | ||
| High | 1.27 on 09/18/19 | 22.32 on 03/18/24 | 5.96 on 03/07/24 | ||
| 6-Month | |||||
| %Chg | -53.10% since 04/08/19 | -38.69% since 11/15/23 | +25.06% since 11/15/23 | ||
| Low | 0.54 on 10/08/19 | 10.60 on 05/03/24 | 1.59 on 02/01/24 | ||
| High | 1.60 on 04/11/19 | 22.32 on 03/18/24 | 5.96 on 03/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,341 | 13,876 | 13,332 | ||
| Shares Outstanding, K | 19,619 | 1,237 | 5,700 | ||
| Annual Sales | 130,430,000 | 42,810,000 | 1,210,000 | ||
| Annual Net Income | -108,330,000 | -24,540,000 | -2,550,000 | ||
| Last Quarter Sales | N/A | 1,300,000 | N/A | ||
| Last Quarter Net Income | N/A | -4,580,000 | N/A | ||
| 60-Month Beta | 2.12 | 0.55 | 1.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -4.00 on 03/29/24 | N/A | ||
| Latest Earnings Date | 11/08/19 | 05/15/24 | 08/30/23 | ||
| Most Recent Dividend | 3.915 on 06/28/13 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||